These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 24944644)

  • 1. Action of melatonin on squamous cell carcinoma and other tumors of the oral cavity (Review).
    Cutando A; López-Valverde A; DE Vicente J; Gimenez JL; Carcía IA; DE Diego RG
    Oncol Lett; 2014 Apr; 7(4):923-926. PubMed ID: 24944644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin and cancer: current knowledge and its application to oral cavity tumours.
    Cutando A; Aneiros-Fernández J; Aneiros-Cachaza J; Arias-Santiago S
    J Oral Pathol Med; 2011 Sep; 40(8):593-7. PubMed ID: 21284745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related decline in melatonin and its MT1 receptor are associated with decreased sensitivity to melatonin and enhanced mammary tumor growth.
    Hill SM; Cheng C; Yuan L; Mao L; Jockers R; Dauchy B; Blask DE
    Curr Aging Sci; 2013 Feb; 6(1):125-33. PubMed ID: 23895529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new perspective in Oral health: potential importance and actions of melatonin receptors MT1, MT2, MT3, and RZR/ROR in the oral cavity.
    Cutando A; Aneiros-Fernández J; López-Valverde A; Arias-Santiago S; Aneiros-Cachaza J; Reiter RJ
    Arch Oral Biol; 2011 Oct; 56(10):944-50. PubMed ID: 21459362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of melatonin and melatonin receptors ligand N-[(4-methoxy-1H-indol-2-yl)methyl]propanamide on murine Colon 38 cancer growth in vitro and in vivo.
    Winczyk K; Pawlikowski M; Lawnicka H; Kunert-Radek J; Spadoni G; Tarzia G; Karasek M
    Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():50-4. PubMed ID: 12019352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible involvement of the nuclear RZR/ROR-alpha receptor in the antitumor action of melatonin on murine Colon 38 cancer.
    Winczyk K; Pawlikowski M; Guerrero JM; Karasek M
    Tumour Biol; 2002; 23(5):298-302. PubMed ID: 12595746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncostatic activities of melatonin: Roles in cell cycle, apoptosis, and autophagy.
    Targhazeh N; Reiter RJ; Rahimi M; Qujeq D; Yousefi T; Shahavi MH; Mir SM
    Biochimie; 2022 Nov; 202():34-48. PubMed ID: 35752221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin suppresses aromatase expression and activity in breast cancer associated fibroblasts.
    Knower KC; To SQ; Takagi K; Miki Y; Sasano H; Simpson ER; Clyne CD
    Breast Cancer Res Treat; 2012 Apr; 132(2):765-71. PubMed ID: 22237979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melatonin.
    Mor M; Plazzi PV; Spadoni G; Tarzia G
    Curr Med Chem; 1999 Jun; 6(6):501-18. PubMed ID: 10213796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth-inhibitory activity of melatonin on murine foregastric carcinoma cells in vitro and the underlying molecular mechanism.
    Xu L; Liu H; Zhang H; Wang RX; Song J; Zhou RX
    Anat Rec (Hoboken); 2013 Jun; 296(6):914-20. PubMed ID: 23564716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Luzindole but not 4-phenyl-2- propionamidotetralin (4P-PDOT) diminishes the inhibitory effect of melatonin on murine Colon 38 cancer growth in vitro.
    Winczyk K; Fuss-Chmielewska J; Lawnicka H; Pawlikowski M; Karasek M
    Neuro Endocrinol Lett; 2009; 30(5):657-62. PubMed ID: 20035258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Review on Melatonin's Effects in Cancer: Potential Mechanisms.
    Hanikoglu A; Kucuksayan E; Akduman RC; Ozben T
    Anticancer Agents Med Chem; 2018; 18(7):985-992. PubMed ID: 29173185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin MT
    López-Canul M; Min SH; Posa L; De Gregorio D; Bedini A; Spadoni G; Gobbi G; Comai S
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31108968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Declining melatonin levels and MT1 receptor expression in aging rats is associated with enhanced mammary tumor growth and decreased sensitivity to melatonin.
    Hill SM; Cheng C; Yuan L; Mao L; Jockers R; Dauchy B; Frasch T; Blask DE
    Breast Cancer Res Treat; 2011 May; 127(1):91-8. PubMed ID: 20549340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncostatic activity of pineal neuroendocrine treatment with the pineal indoles melatonin and 5-methoxytryptamine in untreatable metastatic cancer patients progressing on melatonin alone.
    Lissoni P; Rovelli F; Frassineti A; Fumagalli L; Malysheva O; Conti A; Maestroni G
    Neuro Endocrinol Lett; 2000; 21(4):319-323. PubMed ID: 11455367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a role for melatonin in supportive care?
    Lissoni P
    Support Care Cancer; 2002 Mar; 10(2):110-6. PubMed ID: 11862501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemotherapy with immunomodulating pineal hormones other than melatonin: 5-methoxytryptamine as a new oncostatic pineal agent.
    Lissoni P
    Pathol Biol (Paris); 2007; 55(3-4):198-200. PubMed ID: 17451889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin downregulates nuclear receptor RZR/RORγ expression causing growth-inhibitory and anti-angiogenesis activity in human gastric cancer cells
    Wang RX; Liu H; Xu L; Zhang H; Zhou RX
    Oncol Lett; 2016 Aug; 12(2):897-903. PubMed ID: 27446366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin anticancer effects: review.
    Di Bella G; Mascia F; Gualano L; Di Bella L
    Int J Mol Sci; 2013 Jan; 14(2):2410-30. PubMed ID: 23348932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemotherapy with standard chemotherapies plus the pineal hormone melatonin in the treatment of advanced solid neoplasms.
    Lissoni P
    Pathol Biol (Paris); 2007; 55(3-4):201-4. PubMed ID: 17446010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.